Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000914190-14-000014
Filing Date
2014-01-28
Accepted
2014-01-28 16:24:32
Documents
1
Period of Report
2014-01-24

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 18070
  Complete submission text file 0000914190-14-000014.txt   19550
Mailing Address 200 ROUTE 31 NORTH SUITE 104 FLEMINGTON NJ 08822
Business Address 200 ROUTE 31 NORTH SUITE 104 FLEMINGTON NJ 08822 (862) 703-7175
Arno Therapeutics, Inc (Issuer) CIK: 0001195116 (see all company filings)

EIN.: 522286452 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 200 ROUTE 31 NORTH SUITE 104 FLEMINGTON NJ 08822
Business Address
Zukiwski Alexander A (Reporting) CIK: 0001569782 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-52153 | Film No.: 14553294